Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5025,800.61.12%H 25,808.8 · L 25,345.2as of 20 Nov, 3:31 PM IST|Sensex83,919.711.08%H 84,037.96 · L 82,403.27as of 20 Nov, 3:32 PM IST|Bank Nifty64,635.22.49%H 64,680.8 · L 62,598.55as of 20 Nov, 3:31 PM IST|USD / INR₹92.670.65%H ₹92.67 · L ₹92.67as of 9:00 AM IST|Gold Intl (10g)₹1,04,738.094.62%H ₹1,08,393.82 · L ₹1,04,365.66as of 3:29 AM IST|Silver Intl (1kg)₹1,22,364.267.41%H ₹1,28,650.81 · L ₹1,21,008.63as of 3:29 AM IST|Crude WTI₹7,729.61.18%H ₹7,790.77 · L ₹7,485.88as of 3:29 AM IST|Bitcoin₹53,65,7346%H ₹55,26,750.65 · L ₹52,04,717.35upd. 3:06 PM IST|Ethereum₹1,51,6556.22%H ₹1,56,373.33 · L ₹1,46,936.67upd. 3:06 PM IST|Nifty 5025,800.61.12%H 25,808.8 · L 25,345.2as of 20 Nov, 3:31 PM IST|Sensex83,919.711.08%H 84,037.96 · L 82,403.27as of 20 Nov, 3:32 PM IST|Bank Nifty64,635.22.49%H 64,680.8 · L 62,598.55as of 20 Nov, 3:31 PM IST|USD / INR₹92.670.65%H ₹92.67 · L ₹92.67as of 9:00 AM IST|Gold Intl (10g)₹1,04,738.094.62%H ₹1,08,393.82 · L ₹1,04,365.66as of 3:29 AM IST|Silver Intl (1kg)₹1,22,364.267.41%H ₹1,28,650.81 · L ₹1,21,008.63as of 3:29 AM IST|Crude WTI₹7,729.61.18%H ₹7,790.77 · L ₹7,485.88as of 3:29 AM IST|Bitcoin₹53,65,7346%H ₹55,26,750.65 · L ₹52,04,717.35upd. 3:06 PM IST|Ethereum₹1,51,6556.22%H ₹1,56,373.33 · L ₹1,46,936.67upd. 3:06 PM IST|
0%
IPOsBreaking

Integris Medtech IPO: Medical Device Maker Files for Public Listing; Check Details

Arth Vani DeskPublished: 1 min read
Integris Medtech IPO: Medical Device Maker Files for Public Listing; Check Details

Source: GNews IPO

Arth Insight · What this means for your wallet

Immediate action
Monitor the official SEBI filing or the company's investor relations page for the announcement of the price band and subscription dates.
  • Integris Medtech is launching an IPO to fund its expansion in the medical device sector.
  • The issue will likely include a fresh issue of shares to reduce debt and fund capital expenditure.
  • The company aims to benefit from the growing demand for domestic medical manufacturing in India.
Recommended for you
Track live & upcoming IPOs
View IPO Center
Listen to this article
AI voice · Podcast mode
Get IPO & market alerts free on Telegram / WhatsApp
AI Summary

Medical technology firm Integris Medtech is preparing for its initial public offering (IPO) to expand its footprint in the Indian healthcare sector. The company aims to raise capital for growth and general corporate purposes through this fresh issue.

Key Highlights
  • ▸Integris Medtech is launching an IPO to fund its expansion in the medical device sector.
  • ▸The issue will likely include a fresh issue of shares to reduce debt and fund capital expenditure.
  • ▸The company aims to benefit from the growing demand for domestic medical manufacturing in India.
  • ▸Final dates, price band, and lot size are currently under regulatory review.
Key Takeaways
  • ✓Integris Medtech is launching an IPO to fund its expansion in the medical device sector.
  • ✓The issue will likely include a fresh issue of shares to reduce debt and fund capital expenditure.
  • ✓The company aims to benefit from the growing demand for domestic medical manufacturing in India.
  • ✓Final dates, price band, and lot size are currently under regulatory review.

Integris Medtech, a prominent player in the Indian medical devices industry, has initiated the process for its Initial Public Offering (IPO). The company, known for manufacturing high-quality medical equipment and consumables, is looking to tap into the primary market to fund its next phase of expansion and strengthen its balance sheet.

IPO Structure and Issue Size

While the specific price band and exact issue size are currently being finalized in consultation with the book-running lead managers, the IPO is expected to consist of a fresh issue of equity shares. The proceeds from the fresh issue are slated to be utilized for capital expenditure, repayment of certain borrowings, and meeting general corporate requirements. This move comes at a time when the Indian medical technology sector is witnessing significant growth driven by increased healthcare spending and the 'Make in India' initiative.

Company Profile and Market Position

Integris Medtech has established itself as a reliable manufacturer in the med-tech space, focusing on products that cater to critical care and surgical requirements. By listing on the exchanges, the company aims to enhance its brand visibility and provide liquidity to its existing shareholders. The Indian medical device market is currently dominated by imports, providing a significant tailwind for domestic manufacturers like Integris to capture market share through localized production.

What Investors Should Watch

Potential investors should keep a close eye on the Draft Red Herring Prospectus (DRHP) for detailed financial health indicators, including revenue growth, EBITDA margins, and debt-to-equity ratios. As the medical device industry is highly regulated, the company’s compliance track record with organizations like the CDSCO (Central Drugs Standard Control Organisation) will be a critical factor for long-term valuation.

  • Price Band: To be announced soon.
  • Lot Size: To be determined based on the final price.
  • Listing: Expected on both NSE and BSE.

The timeline for the IPO, including the opening and closing dates for subscription, will be notified once the regulator provides the final observations on the offer documents. Retail investors are advised to monitor the Grey Market Premium (GMP) and brokerage reports once the price band is officially declared.

This report is for informational purposes only and does not constitute financial or investment advice. Please consult a SEBI-registered advisor before investing.

Recommended for you
Products related to this story — compare & act
Smart picks
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
13.8%
3Y CAGR
Bharat Mobility IPO
Mainboard · Auto
+20.5%
GMP
View IPO
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
12.8%
3Y CAGR
GreenVolt Energy IPO
Mainboard · Renewables
+13.8%
GMP
View IPO
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
12.7%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
12.7%
3Y CAGR

IPO investments are subject to market risk and allotment. Read the RHP / prospectus before applying; grey-market premium (GMP) is unofficial and unreliable. Some listings may be sponsored. Not investment advice.

Frequently Asked Questions

What is the business model of Integris Medtech?

Integris Medtech manufactures and supplies medical devices and equipment, focusing on critical care and surgical segments in the Indian healthcare market.

When will the Integris Medtech IPO open for subscription?

The specific dates for the IPO have not been announced yet; they will be finalized after the company receives regulatory clearance.

How will the company use the IPO proceeds?

The funds raised will be used for capital expenditure, repayment of existing debts, and general corporate purposes.

Stay ahead of the market

Join the Arth Vani channels

Daily news summaries, IPO & market alerts on Telegram and WhatsApp.